Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pfizer
Pfizer
Pfizer tops Dow's intellectual heap, with J&J and Merck close behind: study
Fierce Pharma
Mon, 12/4/17 - 11:45 am
Pfizer
JNJ
Merck
3 Reasons Pfizer Should Buy Celgene in 2018
Motley Fool
Mon, 12/4/17 - 09:51 am
Pfizer
Celgene
M&A
Regeneron CEO Schleifer, a year after public Pfizer spat, slams Allergan for tribal deal
Fierce Pharma
Fri, 12/1/17 - 12:39 pm
Regeneron
Allergan
Pharma CEOs
Leonard Schleifer
Pfizer
patents
Restasis
Pfizer's Prevnar 13 set for another price hike in 2018 as U.S. price-per-dose climbs near $180
Fierce Pharma
Wed, 11/29/17 - 09:57 am
Pfizer
Prevnar 13
vaccines
drug pricing
UK gives Pfizer world's first over-the-counter Viagra approval
Yahoo/Reuters
Tue, 11/28/17 - 10:53 am
Pfizer
OTC
Viagra
UK
erectile dysfunction
Pfizer, Merck KGaA run into a severe setback as PD-L1 drug Bavencio fails in PhIII gastric cancer study
Endpoints
Tue, 11/28/17 - 10:11 am
Pfizer
Merck KGaA
Bavencio
anti-PD-L1
gastric cancer
With $2.5B in Herceptin sales on the line, Roche sues Pfizer for biosim patent infringement
Fierce Pharma
Tue, 11/21/17 - 12:14 pm
Herceptin
Roche
Pfizer
biosimilars
breast cancer
Nevada refusing Pfizer demand for return of execution drugs
Yahoo/AP
Sat, 11/18/17 - 09:59 am
Pfizer
execution drugs
Nevada
Fentanyl
Cancer Space Update: Label Expansion for Three Major Drugs
Yahoo/Zacks.com
Fri, 11/17/17 - 11:45 am
cancer
labeling
AstraZeneca
Faslodex
Pfizer
Sutent
kidney cancer
Roche
Gazyva
follicular lymphoma
Pfizer's Ibrance, Novartis' Kisqali go to battle in England after discounts twin NICE recommendations
Fierce Pharma
Thu, 11/16/17 - 11:07 am
Pfizer
Ibrance
Novartis
Kisqali
England
breast cancer
UK
NICE
Pfizer unveils plan to replace Ian Read
GoinPharma
Tue, 11/14/17 - 07:43 am
Pfizer
Pharma CEOs
Ian Read
Albert Bourla
Forget BMS. Pfizer should chase a Biogen buy, analyst suggests
Fierce Pharma
Mon, 11/13/17 - 08:53 pm
Pfizer
Bristol-Myers Squibb
Biogen
M&A
Pfizer creates chief operating officer role for Bourla
Reuters
Mon, 11/13/17 - 08:41 pm
Pfizer
Albert Bourla
Ian Read
Pfizer exits China joint venture for generic drugs
Yahoo/Reuters
Fri, 11/10/17 - 10:25 pm
Pfizer
China
generic drugs
Zhejiang Hisun Pharma
Novartis takes fight to Pfizer's Ibrance with new Kisqali data
Yahoo/Reuters
Wed, 11/8/17 - 10:10 am
Novartis
Pfizer
Ibrance
Kisqali
breast cancer
With new FDA nod, Roche's Alecensa set to challenge Pfizer, Novartis in first-line lung cancer
Fierce Pharma
Tue, 11/7/17 - 10:55 am
Roche
Alecensa
Pfizer
Novartis
lung cancer
Zykadia
Xalkori
Humira back on top of TV spending list for October, ahead of Lyrica and Victoza
Fierce Pharma
Mon, 11/6/17 - 10:12 am
Humira
Lyrica
Victoza
AbbVie
Pfizer
Novo Nordisk
television ads
DTC ads
Drug executives expect Amazon to shake up distribution
Fierce Pharma
Thu, 11/2/17 - 09:18 am
Amazon
distribution
Pfizer
Ian Read
Don't count out a consumer spinoff, Pfizer execs say amid Q3 M&A grilling
Fierce Pharma
Tue, 10/31/17 - 09:19 pm
Pfizer
consumer health
M&A
Pfizer ready for a fight as biosimilar sales continue to lag
BioPharma Dive
Tue, 10/31/17 - 09:16 pm
Pfizer
biosimilars
Inflectra
Remicade
JNJ
Pages
« first
‹ previous
…
105
106
107
108
109
110
111
112
113
…
next ›
last »